Our aim was to review clinical outcome and patient satisfaction after cataract surgery to obtain spectacle independence following multifocal intraocular lens (IOL) implantation. A prospective case-series study was designed to evaluate the safety and efficacy of the Hanita FullRange pseudophakic multifocal intraocular lens in patients with programmed cataract surgery, performed between October 2017 and May 2018, with follow-up after 12 months. Manifest refraction spherical equivalent (SE), SE refractive accuracy, uncorrected distance (UDVA), intermediate (UIVA) and near visual acuity (UNVA) and a binocular defocus curve were evaluated. In addition, a short “satisfaction questionnaire” was developed. Surgeries were performed without viscoelastic substance. The corneal endothelial cell density (ECD), central corneal thickness (CCT) and intraocular pressure (IOP) were also evaluated. A total of 480 eyes of 240 patients with mean ± standard deviation (SD) of age of 75 ± 6.12 years were included. The mean ± standard deviation (SD) of preoperative SE was 2.0 ± 2.18 D (range; -5.50 to 4.75) which decreased to -0.04 ± 0.28 D (range; -0.75 to 0.625) 12 months after surgery. Regarding SE refractive accuracy 82.9 % of eyes obtained SE values between -0.5 and 0.5 D. There was no loss of lines of vision and 98.3% of patients achieved UDVA between 20/20 and 20/25. The UNVA (binocular) obtained was J1 for 72.5% and J2 for 27.5% of patients. Regarding defocus curve, 0.04 logMAR for -3.0 D, 0.09 logMAR for -1.5 D and 0.03 logMAR for 0 D was achieved. The mean CCT was increased by 6.62 ± 2.79 micrometer (1.24%), the mean ECD was decreased by 226.08 ± 11.63 cell/mm2 (9.00 %) and the IOP remained stable one year after surgery. In response to the satisfaction questionnaire, 92% of patients stated that they had obtained spectacle independence. Finally, spectacle independence was achieved in most of the cases, with a high level of patient satisfaction one year after implantation of a FullRange IOL. No complications were detected. We concluded that the refractive efficacy of FullRange multifocal IOL was proved in majority of cases. A large follow up period is necessary in future studies to confirm the results. KEY
Medical Hypothesis, Discovery & Innovation Ophthalmology Journal
Spectacle Independence After Cataract Surgery: A Prospective Study With a Multifocal Intraocular Lens
German R Bianchi, MD
(2020)
A study of 240 patients who received the FullRange multifocal IOL showed excellent visual outcomes, with 98.3% achieving 20/20 to 20/25 distance vision and 92% reporting spectacle independence one year after cataract surgery. Refractive accuracy was high, with 82.9% of eyes within ±0.5 D of target refraction. Patient satisfaction was notable, with strong near and intermediate visual performance and no reported complications. Future studies with longer follow-up will help further confirm these results.
STAY INFORMED
Signup to get the first look at new products, publications, and events
Related publications
Archives of Ophthalmology and Optometry
Adam Cywinski, Paulina Bazgier
This prospective study evaluated the performance of the Hanita Intensity penta-focal intraocular lens (IOL) in cataract and refractive lens exchange (RLE) patients over an 18-month period. The results demonstrated strong visual outcomes at all distances, with high patient satisfaction and statistically superior distance vision compared to PanOptix.
Therapeutic Advances in Ophthalmology
Germán R. Bianchi
This ambispective, non-randomized study evaluated the visual performance, safety, and patient satisfaction of the Intensity SL (Hanita Lenses) five-focus pseudophakic intraocular lens (IOL) over a 24-month period. The study included 120 eyes of 60 patients who underwent femtosecond laser-assisted bilateral cataract surgery. At two years postoperatively, patients demonstrated excellent uncorrected visual acuity across far, intermediate, and near distances (binocular UDVA −0.05 ± 0.05 logMAR; UIVA 0.009 ± 0.05; UNVA 0.04 ± 0.06). Visual stability was maintained between the 6- and 24-month follow-ups. Dysphotopsias such as glare and halos were rare and mild. Patient satisfaction was remarkably high, with 95% reporting being "very satisfied" and 100% indicating they would choose the same IOL again. The findings support the long-term visual efficacy and quality-of-life benefits of the Intensity SL IOL.
Nature Eye
Jorge L. Alió et al.
This study assessed the refractive outcomes, optical performance, and quality of vision in patients implanted with the Intensity Hanita diffractive intraocular lens (IOL). The prospective, observational study included 64 eyes that underwent bilateral cataract surgery with Intensity IOL implantation, with evaluations conducted at 6 months post-surgery. Results indicated that 66% of eyes achieved uncorrected distance visual acuity (UDVA) of 0.10 logMAR or better. The defocus curve showed optimal vision at distance (0.02 ± 0.07 logMAR at 0.0 D) with stable performance through intermediate and near vision ranges (0.11 ± 0.08 logMAR at -1.5 D, 0.12 ± 0.12 logMAR at -2.5 D). Contrast sensitivity remained stable (p ≥ 0.06), and high-order aberrations were low, with a Strehl ratio of 0.12 ± 0.04. Mild halos and glare were reported but did not interfere significantly with daily activities, and the near activity visual questionnaire (NAVQ) indicated high patient satisfaction with near-vision tasks. These findings support the Intensity Hanita IOL’s effectiveness in providing clear vision across all distances through a five-foci distribution design that enhances depth of focus.